← Leaderboards
Guangdi Wang
Xavier University Of Louisiana
$13,394,490
Attributed
$15,819,458
Total exposure
23
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $8.4M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$58,012,675 · 25
By mechanism
U54$42,499,911 · 15
G12$14,203,522 · 6
S06$752,349 · 1
R21$353,750 · 1
R03$146,000 · 1
R24$57,143 · 1
Top collaborators
- Gene D'Amour35 shared
- Christopher Williams5 shared
Most similar at Xavier University Of Louisiana
Same institution · by research overlap
- Beverly H Wright$22,948,651
- Tien L Huang$1,093,958
- Gene D'amour$16,216,418
- Shashikant K Phadtare$1,714,970
- Kelly Elaine Johanson$422,925
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelCommunitiesUniversitiesGrantProgramsHealth DisparityResearch Project GrantsFacultyBiomedical ResearchServicesLouisianaTrainingUnited States National Institutes Of HealthCore FacilityFundingSuccessResourcesMemberProductivityMentorsPeer ReviewAreaPilot ProjectsAfrican American
Grant awards (78)
The RCMI Center for Cancer and Health Disparities Research$4,656,808
U54 · FY2025 · MD · contact PI
RCMI Administrative Core$624,044
U54 · FY2025 · MD · contact PI
Targeted Degradation of HIV Integrase as a Novel Treatment of Infection$180,263
R21 · FY2025 · AI · contact PI
RCMI Administrative Core$75,000
U54 · FY2025 · MD · contact PI
Evaluating DR2 agonism as a potential therapeutic approach to substance abuse and traumatic brain injury$75,000
U54 · FY2025 · MD · contact PI
RCMI Center for Cancer and Health Disparities Research$4,798,100
U54 · FY2024 · MD · contact PI
RCMI Administrative Core$636,340
U54 · FY2024 · MD · contact PI
Targeted Degradation of HIV Integrase as a Novel Treatment of Infection$173,487
R21 · FY2024 · AI · contact PI
RCMI Center for Cancer and Health Disparities Research$3,331,400
U54 · FY2023 · MD · contact PI
Xavier RCMI Renewal Application-Overall$2,841,178
U54 · FY2023 · MD · contact PI
RCMI Administrative Core$439,537
U54 · FY2023 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$374,990
U54 · FY2023 · MD · contact PI
Development of novel therapeutics to block Alzheimer's Disease progression$374,990
U54 · FY2023 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$341,168
U54 · FY2023 · MD · contact PI
Developing an Orally Bioavailable SERD for Treatment of Metastatic/Advanced Breast Cancer$310,104
U54 · FY2023 · MD · contact PI
RCMI Administrative Core$211,310
U54 · FY2023 · MD · contact PI
Developing a First in Class Reverse Transcriptase Degrader for the Treatment of HIV Infection$211,310
U54 · FY2023 · MD · contact PI
Xavier RCMI Renewal Application-Overall$3,045,081
U54 · FY2022 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$1,197,728
U54 · FY2022 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$373,357
U54 · FY2022 · MD · contact PI
Xavier RCMI Renewal Application-Overall$373,357
U54 · FY2022 · MD · contact PI
Xavier RCMI Renewal Application-Overall$229,475
U54 · FY2022 · MD · contact PI
Developing an Orally Bioavailable SERD for Treatment of Metastatic/Advanced Breast Cancer$208,884
U54 · FY2022 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$198,914
U54 · FY2022 · MD · contact PI
Black Bodies Matter: An examination of Diabetes, Peripheral Artery Disease and Limb Amputation Disparities in Black and White participants of the All of Us Research Program.$198,914
U54 · FY2022 · MD · contact PI
Xavier RCMI Renewal Application-Overall$3,030,676
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$807,327
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$560,378
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Overall$560,378
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$369,987
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Overall$369,987
U54 · FY2021 · MD · contact PI
COVID-19 Vaccine Education at the Point of Testing to Increase Vaccine Uptake in Vulnerable Communities in Southeastern Louisiana$369,149
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$369,149
U54 · FY2021 · MD · contact PI
Developing an Orally Bioavailable SERD for Treatment of Metastatic/Advanced Breast Cancer$251,340
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$148,592
U54 · FY2021 · MD · contact PI
Assessing Vaccine Hesitancy and a Pharmacist Led Intervention Model to Increase COVID-19 Vaccine Uptake Among African Americans$148,592
U54 · FY2021 · MD · contact PI
Aging in Place: The Effect of Housing Arrangements on Quality of Life$125,000
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$125,000
U54 · FY2021 · MD · contact PI
Targeting Neurokinin Receptors to Regulate of Nicotine Reward$75,000
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$75,000
U54 · FY2021 · MD · contact PI
Xavier RCMI Renewal Application-Overall$3,076,195
U54 · FY2020 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$367,125
U54 · FY2020 · MD · contact PI
Examining the Role of Neighborhood Conditions, C-Reactive Protein, and Psychosocial Resiliency Factors in Cognitive Impairment among Diverse US Older Adults$354,999
U54 · FY2020 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$354,999
U54 · FY2020 · MD · contact PI
Administrative Core$348,650
U54 · FY2020 · MD · contact PI
Development of Therapeutics Targeting Tauopathy for Alzheimers Disease$348,650
U54 · FY2020 · MD · contact PI
Developing an Orally Bioavailable SERD for Treatment of Metastatic/Advanced Breast Cancer$327,475
U54 · FY2020 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$200,000
U54 · FY2020 · MD · contact PI
Enhancing Louisiana Health Professionals in Communication Methods/Strategies to Increase COVID 19 Vaccination Rates of Residents of Vulnerable Communities (LaHealthCom)$200,000
U54 · FY2020 · MD · contact PI
Xavier RCMI Renewal Application-Overall$3,672,036
U54 · FY2019 · MD · contact PI
Xavier RCMI Renewal Application-Administrative Core$369,407
U54 · FY2019 · MD · contact PI
Developing an Orally Bioavailable SERD for Treatment of Metastatic/Advanced Breast Cancer$367,831
U54 · FY2019 · MD · contact PI
Xavier RCMI Center for Cancer Research$2,197,654
G12 · FY2018 · MD
DDD Core$700,360
G12 · FY2018 · MD
Cell & Molecular Biology Core$372,829
G12 · FY2018 · MD
Major Instrumentation Core$310,459
G12 · FY2018 · MD
Xavier RCMI Center for Cancer Research$2,297,654
G12 · FY2017 · MD
DDD Core$758,272
G12 · FY2017 · MD
Major Instrumentation Core$476,886
G12 · FY2017 · MD
Cell & Molecular Biology Core$403,881
G12 · FY2017 · MD
Xavier RCMI Center for Cancer Research$234,125
G12 · FY2017 · MD
Xavier RCMI Center for Cancer Research$2,596,980
G12 · FY2016 · MD
Xavier RCMI Center for Cancer Research$202,875
G12 · FY2016 · MD
Xavier RCMI Center for Cancer Research$2,197,654
G12 · FY2015 · MD
Xavier RCMI Center for Cancer Research$948,273
G12 · FY2015 · MD
Xavier RCMI Center for Cancer Research$505,620
G12 · FY2015 · MD
Search for New Cannabinoid Receptor Ligands$136,124
S06 · FY2007 · GM · contact PI
Search for New Cannabinoid Receptor Ligands$81,280
S06 · FY2006 · GM · contact PI
Search for New Cannabinoid Receptor Ligands$78,993
S06 · FY2005 · GM
RECEPTER BINDING PROPERTIES OF CANNABINOID METABOLITES$73,000
R03 · FY2005 · DA
Search for New Cannabinoid Receptor Ligands$81,772
S06 · FY2004 · GM
RECEPTOR BINDING PROPERTIES OF CANNABINOID METABOLITES$73,000
R03 · FY2004 · DA
CANNABIMIMETIC ACTIVITIES--CB1 METABOLITES AGONISTS/ANTA$148,636
S06 · FY2002 · GM
CANNABIMIMETIC ACTIVITIES--CB1 METABOLITES AGONISTS/ANTA$148,636
S06 · FY2001 · GM
CANNABIMIMETIC ACTIVITIES--CB1 METABOLITES AGONISTS/ANTA$38,454
S06 · FY2001 · GM
CENTRAL CANNABINOID RECEPTOR--AGONIST/ANTAGONIST METABOLISM$0
R24 · FY2001 · DA
CENTRAL CANNABINOID RECEPTOR--AGONIST/ANTAGONIST METABOLISM$57,143
R24 · FY2000 · DA
CANNABIMIMETIC ACTIVITIES--CB1 METABOLITES AGONISTS/ANTA$38,454
S06 · FY2000 · GM